Features | Partner Sites | Information | LinkXpress
Sign In

Screening Mammography for Most Women Recommended Every Two Years

By Medimaging International staff writers
Posted on 17 Feb 2014
Implementation of new guidelines recommending screening mammography every two years for women aged 50 to 74 years would result in breast cancer screening that is just as effective, while saving the United States USD 4.3 billion yearly in healthcare costs, according to new data. The study compared three possible mammography-screening approaches with a model of current US screening practices.

The study’s findings were published on February 4, 2014, in the journal Annals of Internal Medicine. The study’s investigators recommend adoption of guidelines developed in 2009 by the US Preventive Services Task Force (USPSTF; Rockville, MD, USA). Under those guidelines, in addition to biennial screening for women aged 50 to 74, women aged 40 to 49 would be screened according to other risk factors, and women 75 and older would be screened depending on the presence or absence of other diseases.

The study was led by Laura J. Esserman, MD, MBA, a professor of surgery and radiology from the University of California, San Francisco (UCSF; USA), and an internationally known leader in the field of breast cancer. “The USPSTF guidelines are based on the best scientific evidence to date,” said Dr. Esserman, director of the Carol Franc Buck Breast Care Center at the UCSF Helen Diller Family Comprehensive Cancer Care Center. “What we need now is a better way to assess breast cancer risk and implement a more risk-based approach to screening. We have demonstrated that the resources for doing this are already in the system. We should redirect them to learning, enabling change, and improving outcomes.”

Approximately 70% of women in the United States, according to the investigators’ estimate, were screened for breast cancer in 2010, at a cost of USD 7.8 billion. Some women are screened yearly, some biennially, and some are screened on a sporadic basis.

The scientists compared this current outlook of breast cancer screening with three simulated models: annual screening of 85% of women aged 40 to 84, in accordance with recommendations from the American Cancer Society and many other policymaking organizations, at a yearly estimated cost of USD 10.1 billion; biennial screening of 85% of women aged 50 to 70, comparable to guidelines used in many European countries, at a yearly estimated cost of USD 2.6 billion; and screening in accordance with USPSTF recommendations, which the authors estimate would cost USD 3.5 billion per year at a screening rate of 85%.

“Over the last decade, in study after study, it has become very clear that—apart from limited, specific high risk groups—biennial screening is as effective as annual screening mammography,” said Dr. Esserman. “At the same time, annual screening is associated with a greater likelihood of false-positive results, which have an adverse impact on women’s well-being and quality of life. From the viewpoint of women’s health, the USPSTF screening recommendations make sense. “We can go one step further and learn who is at risk for what kind of breast cancer, and over time, further tailor screening by adjusting the age to start and frequency as well as include recommendations for prevention.”

Lead author Cristina O'Donoghue, MD, currently at the University of Illinois at Chicago (IL, USA), but with UCSF at the time of the study, noted that the billions of dollars saved from avoiding less-effective mammography screening could be used to improve women’s health. “We could increase women’s participation in screening, improve routine assessment of breast cancer risk and referral services for women at high risk, offer better genetic counseling for women with a family history of breast cancer and work on improving the quality of screening, with an emphasis on higher-quality mammography read by specialized mammographers,” said Dr. O'Donoghue. “These would be only some of the potential benefits of using our healthcare resources more intelligently.”

Related Links:

University of California, San Francisco
US Preventive Services Task Force

SuperSonic Imagine



view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more


view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
Copyright © 2000-2014 Globetech Media. All rights reserved.